MS Matters: Are current measures of disability progression good enough?

Understanding EDSS


In this first CONy & Teva Neuroscience MS Matters webinar series, Prof. Sven Schippling and Prof. Gavin Giovannoni discuss the EDSS tool as a measure of disability progression in MS and whether it is fit for purpose.



 


Beyond EDSS


Continuing with the first CONy & Teva Neuroscience MS Matters webinar entitled MS Matters: Are current measures of disability progression good enough, Prof. Sven Schippling and Prof. Gavin Giovannoni discuss alternative tools to measure disability progression in MS.



 


Assessing disability progression – a patient's perspective


Listen to the patient’s perspective on the relevance of EDSS in assessing the progression of their disease and which symptoms should be adequately captured in the future.



 


Future perspectives


Prof. Sven Schippling highlights the key messages from the CONy & Teva Neuroscience MS Matters webinar entitled MS Matters: Are current measures of disability progression good enough and give his insights into how disability progression should be measured in the future.


Webinar faculty

Prof. Sven Schippling (Moderator)
Prof. Sven Schippling (Moderator)
University Hospital Zürich, Switzerland
Prof. Gavin Giovannoni
Prof. Gavin Giovannoni
Blizard Institute, Barts and The London School of Medicine and Dentistry, UK